Funded Tech Companies

Syntax Bio

Syntax Bio, based in Chicago, received equity investments through Sigma Group, Astellas Venture Capital and Illumina Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Syntax Bio is a preclinical-stage biotech company overcoming the longstanding challenges in stem cell-derived therapies by directly controlling and accelerating cell differentiation. Our Cellgorithm technology provides control over the complex developmental biology needed to manufacture stem cell-derived cell therapies.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/22/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Flavin

        

Chief Technical Officer

Ryan Clarke

        

Co-Founder

Niko Balanis

        

Co-Founder

Brad Merrill

        

VP - Sales

Nick Timmins

        

Company Investors

• Sigma Group
• Astellas Venture Capital
• Illumina Ventures
• Draper Associates
• IllinoisVENTURES
• Allegis Capital
• Civilization Ventures
• Mayo Clinic
• EGB Ventures
• DCVC Bio
• Portal Innovations
• JDRF T1D Fund

Browse more funded tech companies:

Syntax | Syntax Health

Share this article

About Our VC Deals Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary